[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $anab AnaptysBio shares are soaring following positive trial results and a company split. Barclays initiated coverage with an Overweight rating and a $XX target. ### About $anab AnaptysBio, Inc. (ANAB) is a biotechnology company focused on developing immunotherapies. ### Insights [#](/topic/$anab/insights) - $anab mentions hit XXX which is XXX% higher than it's daily average. - $anab creators hit XX which is XXX% higher than it's daily average. - $anab posts created is up XXX% from the previous week. ### Engagements: XXXXX [#](/topic/$anab/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$anab/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXX **1 Week**: XXXXXX -XX% **1 Month**: XXXXXX -XX% **6 Months**: XXXXXXXXX -XX% **1 Year**: XXXXXXXXX +172% **1-Year High**: XXXXXX on 2025-02-12 **1-Year Low**: XX on 2025-05-20 | Social Network | X | | -------------- | - | | Engagements | XXXXX | ### Mentions: XXX [#](/topic/$anab/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$anab/time-series/posts_active.tsv) **Current Value**: XXX **Daily Average**: XX **1 Month**: XXX +465% **6 Months**: XXXXX +29% **1 Year**: XXXXX +248% **1-Year High**: XXX on 2025-10-03 **1-Year Low**: X on 2025-09-14 | Social Network | X | | -------------- | - | | Mentions | XXX | ### Creators: XX [#](/topic/$anab/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$anab/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning $anab in the last XX hours which is up XXX% from XX in the previous XX hours **Daily Average**: XX **1 Month**: XXX +633% **6 Months**: XXX +249% **1 Year**: XXXXX +379% **1-Year High**: XXX on 2025-06-27 **1-Year Low**: X on 2025-09-14 The most influential creators that mention $anab in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@guydroog](/creator/twitter/guydroog) | X | XXXXX | X | XX | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X | XXXXXX | X | XX | | [@jorgesa_1](/creator/twitter/jorgesa_1) | X | XXX | X | XX | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X | XXXXX | X | XX | | [@Brittan48189818](/creator/twitter/Brittan48189818) | X | XXX | X | XX | | [@MiriamF24887120](/creator/twitter/MiriamF24887120) | X | XX | X | XX | | [@bioinvestor24](/creator/twitter/bioinvestor24) | X | XXXXX | X | XX | | [@OzmosiHealth](/creator/twitter/OzmosiHealth) | X | XXXXX | X | XX | | [@IllyrianSpartan](/creator/twitter/IllyrianSpartan) | X | XXXXX | X | XX | | [@Jokerparabol](/creator/twitter/Jokerparabol) | XX | XXXXX | X | X | [View More](/list/creators/$anab/100) ### Sentiment: XX% [#](/topic/$anab/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$anab/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% no change **1 Month**: XX% -XX% **6 Months**: XX% -XX% **1 Year**: XX% -XX% **1-Year High**: XXX% on 2024-10-18 **1-Year Low**: XX% on 2025-09-10 **Most Supportive Themes** - **Company Split and Buyback:** (40%) Positive sentiment surrounds the announcement of AnaptysBio's split into two companies and a $75M buyback program. - **Positive RA Trial Data:** (30%) The lead candidate rosnilimab's positive data in rheumatoid arthritis trials is generating excitement. - **Analyst Upgrades and Price Targets:** (20%) Multiple analysts have raised price targets for $ANAB, indicating confidence in the stock's potential. **Most Critical Themes** - **Market Competition:** (10%) Concerns exist regarding the competitive landscape of the RA treatment market. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXX | XX% | XXX | XX% | XXX | XX% | | | | | | | | | | Total | XXX | XX% | XXX | XX% | XXX | XX% | **Top assets mentioned** In the posts about $anab in the last XX hours [Jigstack (STAK2)](/topic/jigstack) [Jigstack (STAK2)](/topic/$stak) [NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)](/topic/$nams) [Carry (CRE)](/topic/$cre) [Celldex Therapeutics, Inc (CLDX)](/topic/$cldx) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [Eli Lilly and Company (LLY)](/topic/$lly) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Alkermes Inc. plc (ALKS)](/topic/$alks) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) **Top topics mentioned** In the posts about $anab in the last XX hours [coins defi](/topic/coins-defi), [stocks healthcare](/topic/stocks-healthcare), [jigstack](/topic/jigstack), [coins dao](/topic/coins-dao), [$barcl](/topic/$barcl), [stocks technology](/topic/stocks-technology), [$kavl](/topic/$kavl), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$abvx](/topic/$abvx), [$sprc](/topic/$sprc), [$stak](/topic/$stak), [$jfb](/topic/$jfb), [$nams](/topic/$nams), [$cre](/topic/$cre), [$cldx](/topic/$cldx), [eli lilly](/topic/eli-lilly), [$lly](/topic/$lly), [stocks real estate](/topic/stocks-real-estate), [stocks](/topic/stocks), [$cgtx](/topic/$cgtx), [$dmac](/topic/$dmac), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$qcls](/topic/$qcls), [upside](/topic/upside), [$agio](/topic/$agio), [$alks](/topic/$alks), [$bbio](/topic/$bbio), [$elan](/topic/$elan), [$crsp](/topic/$crsp), [positions](/topic/positions), [$bbai](/topic/$bbai), [advanced micro devices](/topic/advanced-micro-devices), [investment](/topic/investment), [stocks financial services](/topic/stocks-financial-services), [$crdf](/topic/$crdf), [$ixhl](/topic/$ixhl), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks communication services](/topic/stocks-communication-services), [$lac](/topic/$lac), [$bkkt](/topic/$bkkt), [money](/topic/money), [atai life](/topic/atai-life), [$crvs](/topic/$crvs), [$phvs](/topic/$phvs), [$cogt](/topic/$cogt), [$ezgo](/topic/$ezgo), [argo blockchain](/topic/argo-blockchain), [stocks bitcoin miners](/topic/stocks-bitcoin-miners), [$bttc](/topic/$bttc), [bitcoin](/topic/bitcoin), [coins layer 1](/topic/coins-layer-1), [coins bitcoin ecosystem](/topic/coins-bitcoin-ecosystem), [coins pow](/topic/coins-pow), [dough](/topic/dough), [$apge](/topic/$apge), [$bhvn](/topic/$bhvn), [$cgen](/topic/$cgen), [$rcus](/topic/$rcus), [$bcax](/topic/$bcax), [$mnkd](/topic/$mnkd), [coins made in usa](/topic/coins-made-in-usa), [$fbrx](/topic/$fbrx), [limits](/topic/limits), [tha](/topic/tha), [$valn](/topic/$valn), [$prok](/topic/$prok), [$tngx](/topic/$tngx), [telegram](/topic/telegram), [$imvt](/topic/$imvt), [$amd](/topic/$amd), [$an](/topic/$an), [$open](/topic/$open), [$ycbd](/topic/$ycbd), [$gran](/topic/$gran), [$sprb](/topic/$sprb), [$cdt](/topic/$cdt), [coins solana ecosystem](/topic/coins-solana-ecosystem), [coins insurance](/topic/coins-insurance), [coins arbitrum](/topic/coins-arbitrum), [coins avalanche](/topic/coins-avalanche), [$pbm](/topic/$pbm), [tanks](/topic/tanks), [$sgtm](/topic/$sgtm), [$celg](/topic/$celg), [$roku](/topic/$roku), [$prgo](/topic/$prgo), [exxon mobil](/topic/exxon-mobil), [stocks energy](/topic/stocks-energy), [$googl](/topic/$googl), [analog devices](/topic/analog-devices), [$adi](/topic/$adi), [$adpt](/topic/$adpt), [$rvyl](/topic/$rvyl), [$litm](/topic/$litm), [$wwr](/topic/$wwr), [$sti](/topic/$sti), [$path](/topic/$path), [$unfi](/topic/$unfi), [$smtc](/topic/$smtc), [$hive](/topic/$hive) ### Top Social Posts [#](/topic/$anab/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* ""Shark Tank's Kevin Harrington Interviews $SGTM CEO Tony Raynor: Insights from the Original Shark" $CELG $BIIB $ANAB $EXAS $OSTK $ROKU $EIGR $FLXN $LJPC $PLXP $RARX $SYRS $IBB $XBI $VSTM $CRBP $GILD $AMGN $ABBV $LGND $ALNY $GERN $ALXN $PG $MRK $JNJ" [X Link](https://x.com/MoneyMaker0009/status/1978821144066105740) [@MoneyMaker0009](/creator/x/MoneyMaker0009) 2025-10-16T13:51Z XXX followers, XXX engagements "ANAB - I Have a CakeWhen Can I Eat It Too: ANAB R&D Day Takeaways Wedbush Full report in Telegram (in the header)👆 $ANAB $IMVT $MRNA $ARQT $VTYX $KNSA $INSM $PRAX $RARE $FGEN $GLPG $NBIX $ACAD $VKTX $MOR $ZLAB $EXEL $KPTI $IMCR $ABCL $SWTX $OMGA $RNA $ARCT $ALLK $INZY" [X Link](https://x.com/Biobeats99/status/1978596639951446178) [@Biobeats99](/creator/x/Biobeats99) 2025-10-15T22:59Z XXX followers, XXX engagements "$ANAB Somehow missed my alert on this today to pre-position for a bigger breakout. The monthly rectangle bottom looks incredible" [X Link](https://x.com/guydroog/status/1978569735043236165) [@guydroog](/creator/x/guydroog) 2025-10-15T21:12Z 1446 followers, XXX engagements "$AMD -HSBC raises Advanced Micro Devices target to $XXX from $XXX Buy -Wedbush raises target to $XXX from $XXX Outperform - $AN -Wells Fargo trims AutoNation target to $XXX from $XXX = Weight - $ANAB -Wedbush raises AnaptysBio target to $XX from $XX Outperform -" [X Link](https://x.com/MarcJacksonLA/status/1978543844783210858) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-15T19:29Z 7574 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$anab
AnaptysBio shares are soaring following positive trial results and a company split. Barclays initiated coverage with an Overweight rating and a $XX target.
About $anab
AnaptysBio, Inc. (ANAB) is a biotechnology company focused on developing immunotherapies.
Insights #
- $anab mentions hit XXX which is XXX% higher than it's daily average.
- $anab creators hit XX which is XXX% higher than it's daily average.
- $anab posts created is up XXX% from the previous week.
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXX +172%
1-Year High: XXXXXX on 2025-02-12
1-Year Low: XX on 2025-05-20
| Social Network | X |
|---|---|
| Engagements | XXXXX |
Mentions: XXX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
1 Month: XXX +465%
6 Months: XXXXX +29%
1 Year: XXXXX +248%
1-Year High: XXX on 2025-10-03
1-Year Low: X on 2025-09-14
| Social Network | X |
|---|---|
| Mentions | XXX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $anab in the last XX hours which is up XXX% from XX in the previous XX hours
Daily Average: XX
1 Month: XXX +633%
6 Months: XXX +249%
1 Year: XXXXX +379%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-14
The most influential creators that mention $anab in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @guydroog | X | XXXXX | X | XX |
| @BiopharmIQ | X | XXXXXX | X | XX |
| @jorgesa_1 | X | XXX | X | XX |
| @MarcJacksonLA | X | XXXXX | X | XX |
| @Brittan48189818 | X | XXX | X | XX |
| @MiriamF24887120 | X | XX | X | XX |
| @bioinvestor24 | X | XXXXX | X | XX |
| @OzmosiHealth | X | XXXXX | X | XX |
| @IllyrianSpartan | X | XXXXX | X | XX |
| @Jokerparabol | XX | XXXXX | X | X |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% no change
1 Month: XX% -XX%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-10-18
1-Year Low: XX% on 2025-09-10
Most Supportive Themes
- Company Split and Buyback: (40%) Positive sentiment surrounds the announcement of AnaptysBio's split into two companies and a $75M buyback program.
- Positive RA Trial Data: (30%) The lead candidate rosnilimab's positive data in rheumatoid arthritis trials is generating excitement.
- Analyst Upgrades and Price Targets: (20%) Multiple analysts have raised price targets for $ANAB, indicating confidence in the stock's potential.
Most Critical Themes
- Market Competition: (10%) Concerns exist regarding the competitive landscape of the RA treatment market.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXX | XX% | XXX | XX% |
| Total | XXX | XX% | XXX | XX% | XXX | XX% |
Top assets mentioned In the posts about $anab in the last XX hours
Jigstack (STAK2) Jigstack (STAK2) NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) Carry (CRE) Celldex Therapeutics, Inc (CLDX) Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) Agios Pharmaceuticals, Inc. (AGIO) Alkermes Inc. plc (ALKS) BridgeBio Pharma, Inc. Common Stock (BBIO)
Top topics mentioned In the posts about $anab in the last XX hours
coins defi, stocks healthcare, jigstack, coins dao, $barcl, stocks technology, $kavl, stocks bitcoin treasuries, $abvx, $sprc, $stak, $jfb, $nams, $cre, $cldx, eli lilly, $lly, stocks real estate, stocks, $cgtx, $dmac, stocks crypto treasuries, $qcls, upside, $agio, $alks, $bbio, $elan, $crsp, positions, $bbai, advanced micro devices, investment, stocks financial services, $crdf, $ixhl, stocks consumer cyclical, stocks communication services, $lac, $bkkt, money, atai life, $crvs, $phvs, $cogt, $ezgo, argo blockchain, stocks bitcoin miners, $bttc, bitcoin, coins layer 1, coins bitcoin ecosystem, coins pow, dough, $apge, $bhvn, $cgen, $rcus, $bcax, $mnkd, coins made in usa, $fbrx, limits, tha, $valn, $prok, $tngx, telegram, $imvt, $amd, $an, $open, $ycbd, $gran, $sprb, $cdt, coins solana ecosystem, coins insurance, coins arbitrum, coins avalanche, $pbm, tanks, $sgtm, $celg, $roku, $prgo, exxon mobil, stocks energy, $googl, analog devices, $adi, $adpt, $rvyl, $litm, $wwr, $sti, $path, $unfi, $smtc, $hive
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
""Shark Tank's Kevin Harrington Interviews $SGTM CEO Tony Raynor: Insights from the Original Shark" $CELG $BIIB $ANAB $EXAS $OSTK $ROKU $EIGR $FLXN $LJPC $PLXP $RARX $SYRS $IBB $XBI $VSTM $CRBP $GILD $AMGN $ABBV $LGND $ALNY $GERN $ALXN $PG $MRK $JNJ"
X Link @MoneyMaker0009 2025-10-16T13:51Z XXX followers, XXX engagements
"ANAB - I Have a CakeWhen Can I Eat It Too: ANAB R&D Day Takeaways Wedbush Full report in Telegram (in the header)👆 $ANAB $IMVT $MRNA $ARQT $VTYX $KNSA $INSM $PRAX $RARE $FGEN $GLPG $NBIX $ACAD $VKTX $MOR $ZLAB $EXEL $KPTI $IMCR $ABCL $SWTX $OMGA $RNA $ARCT $ALLK $INZY"
X Link @Biobeats99 2025-10-15T22:59Z XXX followers, XXX engagements
"$ANAB Somehow missed my alert on this today to pre-position for a bigger breakout. The monthly rectangle bottom looks incredible"
X Link @guydroog 2025-10-15T21:12Z 1446 followers, XXX engagements
"$AMD -HSBC raises Advanced Micro Devices target to $XXX from $XXX Buy -Wedbush raises target to $XXX from $XXX Outperform - $AN -Wells Fargo trims AutoNation target to $XXX from $XXX = Weight - $ANAB -Wedbush raises AnaptysBio target to $XX from $XX Outperform -"
X Link @MarcJacksonLA 2025-10-15T19:29Z 7574 followers, XXX engagements